Amneal to Virtually Participate at Upcoming Investor Conferences

Rhea-AI Summary

Amneal Pharmaceuticals (NYSE: AMRX) announced its participation in two investor conferences. The RBC Global Healthcare Conference will be held on May 18, 2021, featuring a fireside chat at 1:55 p.m. ET. The Goldman Sachs 42nd Annual Global Healthcare Conference is scheduled for June 10, 2021, with a fireside chat at 3:50 p.m. ET. Both events will be accessible via live webcast on the Company's Investor Relations webpage. Amneal focuses on the development and distribution of generics and specialty products and holds a 65% stake in AvKARE.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that its management team will virtually attend the following investor conferences:

RBC Global Healthcare Conference
May 18, 2021
Fireside Chat – 1:55 p.m. Eastern Time

Goldman Sachs 42^nd Annual Global Healthcare Conference
June 10, 2021
Fireside Chat – 3:50 p.m. Eastern Time

A live webcast of the presentations will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. A replay of the webcast will be posted shortly after the call and will be available for a limited time following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal has an extensive portfolio of approximately 250 product families and is expanding its portfolio to include complex dosage forms, including biosimilars, in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system and endocrine disorders.

The Company also owns 65% of AvKARE. AvKARE provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, primarily focused on serving the Department of Defense and the Department of Veterans Affairs. AvKARE is also a packager and wholesale distributor of pharmaceuticals and vitamins to its retail and institutional customers who are located throughout the United States focused primarily on offering 340b-qualified entities products to provide consistency in care and pricing. For more information, visit www.amneal.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005301/en/

FAQ

When will Amneal Pharmaceuticals participate in the RBC Global Healthcare Conference?

Amneal Pharmaceuticals will participate in the RBC Global Healthcare Conference on May 18, 2021, with a fireside chat at 1:55 p.m. ET.

What date is the Goldman Sachs 42nd Annual Global Healthcare Conference?

The Goldman Sachs 42nd Annual Global Healthcare Conference is scheduled for June 10, 2021.

Where can I watch the Amneal Pharmaceuticals investor conference webcasts?

Webcasts of Amneal Pharmaceuticals' presentations can be accessed through the Investor Relations section of their website.

What is Amneal Pharmaceuticals' focus in the pharmaceutical industry?

Amneal Pharmaceuticals focuses on developing, manufacturing, and distributing generic and specialty drug products.

What is AvKARE and what role does Amneal Pharmaceuticals have in it?

Amneal Pharmaceuticals owns 65% of AvKARE, which provides pharmaceuticals and medical products primarily to government agencies.